经导管门静脉内递送内皮细胞治疗促进肝再生的可行性:肝硬化大型动物模型研究
在猪肝硬化模型中,经影像引导经肝门静脉导管递送自体肝内皮细胞或生理盐水,8头猪均技术成功且无并发症;内皮细胞治疗组肝纤维化和胆管损伤替代标志物均值低于对照组,但差异未达统计学显著;结论确认该技术可行,需更大动物及人体研究证实。
要点
- 影像引导经肝门静脉导管递送内皮细胞在猪肝硬化模型中技术可行,8头均成功且无并发症。
- 治疗后1小时肝内可检出内皮细胞,3周后组织学显示纤维化和胆管损伤标志物均值低于对照但未达显著。
- Masson三色染色阳性像素百分比内皮细胞组7.28% vs 对照组5.57%(P=0.20)。
核心结论
- 结果证实影像引导经导管门静脉内递送内皮细胞治疗肝硬化在猪模型中可行,观察到内皮细胞治疗组肝纤维化减少的趋势,需更大动物研究和人体研究确认显著性。
研究设计与样本
- 可行性动物研究:8头猪经肝动脉灌注乙醇和碘化油诱导肝硬化,3周后随机分为自体内皮细胞治疗组(n=4)和磷酸盐缓冲液对照组(n=4),经影像引导经肝门静脉置管递送,治疗后1小时活检行荧光激活细胞分选分析,3周后处死行定量病理检查,统计采用非配对t检验(不等方差)。
诊断标准与关键数值
- Masson三色染色阳性像素平均百分比内皮细胞组7.28% vs 对照组5.57%(P=0.20);细胞角蛋白广谱增殖指数均值2.55 vs 1.13(P=0.06);Ki67增殖指数均值7.08 vs 4.96(P=0.14),差异均未达统计学显著。
局限性
- 本初步研究中上述指标差异未达统计学显著(Masson三色染色P=0.20、细胞角蛋白广谱P=0.06、Ki67 P=0.14)。
- 需更大动物研究和人体研究确认显著性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To demonstrate the feasibility of imaging-guided catheter-directed delivery of endothelial cell therapy in a porcine model of cirrhosis for liver regeneration. Materials and Methods After approval from the institutional animal care and use committee, autologous liver endothelial cells were grown from core hepatic specimens from swine. Cirrhosis was induced in swine by means of transcatheter infusion of ethanol and iodized oil into the hepatic artery. Three weeks after induction of cirrhosis, the swine were randomly assigned to receive autologous cell therapy (endothelial cells, n = 4) or control treatment (phosphate-buffered saline, n = 4) by means of imaging-guided transhepatic intraportal catheterization. Fluorescence-activated cell sorting analysis was performed on biopsy samples 1 hour after therapy. Three weeks after intraportal delivery of endothelial cells, the swine were euthanized and the explanted liver underwent quantitative pathologic examination. Statistical analysis was performed with an unpaired t test by using unequal variance. Results Liver endothelial cells were successfully isolated, cultured, and expanded from eight 20-mm, 18-gauge hepatic core samples to 50 × 106 autologous cells per pig. Intraportal delivery of endothelial cell therapy or saline was technically successful in all eight swine, with no complications. Endothelial cells were present in the liver for a minimum of 1 hour after intraportal infusion. Swine treated with endothelial cell therapy showed mean levels of surrogate markers of hepatobiliary injury that were consistent with decreases in hepatic fibrosis and biliary ductal damage relative to the control animals, although statistical significance was not met in this pilot study: The mean percentage of positive pixels at Masson trichrome staining was 7.28% vs 5.57%, respectively (P = .20), the mean proliferation index with cytokeratin wide-spectrum was 2.55 vs 1.13 (P = .06), and the mean proliferation index with Ki67 was 7.08 vs 4.96 (P = .14). Conclusion The results confirm the feasibility of imaging-guided catheter-directed endothelial cell therapy with an intraportal technique for the treatment of cirrhosis in a porcine model. A trend toward decreased liver fibrosis with endothelial cell therapy was observed. Larger animal studies and human studies are necessary to confirm significance. © RSNA, 2017.
引用
- Lee KS, Santagostino SF, Li D, et al. Catheter-directed Intraportal Delivery of Endothelial Cell Therapy for Liver Regeneration: A Feasibility Study in a Large-Animal Model of Cirrhosis. Radiology. 2017. PMID: 28498793. doi:10.1148/radiol.2017162617
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。